PMC:7172841 / 1301-1659
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T14 | 71-81 | Body_part | denotes | macrophage | http://purl.org/sig/ont/fma/fma63261 |
T15 | 171-174 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T16 | 186-195 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
T17 | 203-207 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T18 | 212-219 | Body_part | denotes | NK cell | http://purl.org/sig/ont/fma/fma63147 |
T19 | 215-219 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T18 | 21-29 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T19 | 71-101 | Disease | denotes | macrophage activation syndrome | http://purl.obolibrary.org/obo/MONDO_0015545 |
T20 | 112-131 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T21 | 261-269 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T22 | 316-324 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 316-320 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 82-92 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T13 | 151-152 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 186-195 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
T15 | 199-202 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T16 | 203-207 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T17 | 212-219 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T12 | 175-177 | Chemical | denotes | DR | http://purl.obolibrary.org/obo/CHEBI_73445 |
T13 | 273-275 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 71-92 | http://purl.obolibrary.org/obo/GO_0042116 | denotes | macrophage activation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-10 | Sentence | denotes | Highlights |
T13 | 11-101 | Sentence | denotes | • Severe COVID-19 patients display immune dysregulation or macrophage activation syndrome |
T14 | 102-195 | Sentence | denotes | • Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes |
T15 | 196-269 | Sentence | denotes | • CD4 cell and NK cell cytopenias are characteristics of severe COVID-19 |
T16 | 270-358 | Sentence | denotes | • IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T8 | 47-67 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
T9 | 112-131 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
T10 | 338-358 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T44 | 21-29 | SP_7 | denotes | COVID-19 |
T45 | 47-53 | UBERON:0002405 | denotes | immune |
T46 | 54-67 | GO:0065007 | denotes | dysregulation |
T47 | 71-81 | CL:0000235;GO:0042116 | denotes | macrophage |
T48 | 82-92 | GO:0042116 | denotes | activation |
T49 | 112-123 | UBERON:0001004 | denotes | respiratory |
T50 | 171-174 | PR:000029150 | denotes | HLA |
T51 | 181-185 | PR:000001889 | denotes | CD14 |
T52 | 186-195 | CL:0000576 | denotes | monocytes |
T53 | 261-269 | SP_7 | denotes | COVID-19 |
T54 | 273-277 | PR:000001393 | denotes | IL-6 |
T55 | 286-297 | DG_35 | denotes | Tocilizumab |
T56 | 316-326 | SP_7 | denotes | SARS-CoV-2 |
T57 | 345-358 | GO:0065007 | denotes | dysregulation |
T19296 | 21-29 | SP_7 | denotes | COVID-19 |
T3907 | 47-53 | UBERON:0002405 | denotes | immune |
T65562 | 54-67 | GO:0065007 | denotes | dysregulation |
T99154 | 71-81 | CL:0000235;GO:0042116 | denotes | macrophage |
T21216 | 82-92 | GO:0042116 | denotes | activation |
T35889 | 112-123 | UBERON:0001004 | denotes | respiratory |
T52417 | 171-174 | PR:000029150 | denotes | HLA |
T73916 | 181-185 | PR:000001889 | denotes | CD14 |
T86003 | 186-195 | CL:0000576 | denotes | monocytes |
T91561 | 261-269 | SP_7 | denotes | COVID-19 |
T288 | 273-277 | PR:000001393 | denotes | IL-6 |
T45776 | 286-297 | DG_35 | denotes | Tocilizumab |
T71931 | 316-326 | SP_7 | denotes | SARS-CoV-2 |
T97850 | 345-358 | GO:0065007 | denotes | dysregulation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
69 | 30-38 | Species | denotes | patients | Tax:9606 |
70 | 21-29 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 71-101 | Disease | denotes | macrophage activation syndrome | MESH:D055501 |
74 | 181-185 | Gene | denotes | CD14 | Gene:929 |
75 | 112-131 | Disease | denotes | respiratory failure | MESH:D012131 |
79 | 199-202 | Gene | denotes | CD4 | Gene:920 |
80 | 212-230 | Disease | denotes | NK cell cytopenias | MESH:D054066 |
81 | 261-269 | Disease | denotes | COVID-19 | MESH:C000657245 |
85 | 273-277 | Gene | denotes | IL-6 | Gene:3569 |
86 | 316-326 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
87 | 286-297 | Chemical | denotes | Tocilizumab | MESH:C502936 |